A vasopressor is a medication that raises dangerously low blood pressure by tightening blood vessels. These drugs are used in emergency and intensive care settings when a patient’s blood pressure drops so low that vital organs, including the brain, kidneys, and heart, stop receiving enough blood to function. Vasopressors are given through an IV, typically in an ICU where blood pressure can be monitored continuously.
How Vasopressors Work
Your blood vessels are lined with smooth muscle that can contract or relax. Vasopressors target specific receptors on that muscle, triggering it to squeeze tighter. This narrowing of blood vessels, called vasoconstriction, increases the pressure inside the circulatory system the same way squeezing a garden hose increases water pressure at the nozzle.
Most vasopressors work by stimulating a group of receptors called adrenergic receptors. The two most relevant types are alpha-1 receptors and beta-1 receptors. When a drug activates alpha-1 receptors, it causes blood vessels to constrict, which directly raises blood pressure. When it activates beta-1 receptors, it makes the heart beat faster and pump more forcefully, pushing more blood through the system. Different vasopressor drugs hit these receptors in different combinations, which is why doctors choose specific agents depending on the situation.
When Vasopressors Are Used
Vasopressors are reserved for a condition called shock, where blood pressure is too low to keep organs alive. There are four main types of shock: hypovolemic (from severe blood or fluid loss), distributive (from widespread blood vessel relaxation, as in sepsis or severe allergic reactions), cardiogenic (from a failing heart), and obstructive (from something physically blocking blood flow, like a massive blood clot in the lungs).
Doctors don’t reach for vasopressors immediately. In most cases, the first step is pumping IV fluids into the bloodstream to restore volume. Vasopressors come into play when fluids alone aren’t enough. The threshold is a measure called mean arterial pressure, or MAP, which represents the average pressure in your arteries during a full heartbeat cycle. Critical care guidelines set the minimum target at 65 mmHg for most patients. If MAP stays below roughly 60 mmHg after adequate fluids, vasopressor therapy begins.
Some situations call for higher targets. In neurogenic shock, which can follow a spinal cord injury, the goal is to keep systolic blood pressure above 90 mmHg and MAP between 85 and 90 mmHg for the first seven days to protect the injured spinal cord from further damage.
Common Vasopressor Medications
The most widely used vasopressor in critical care is norepinephrine. It strongly activates the receptors that constrict blood vessels while also giving the heart a moderate boost. For septic shock specifically, surviving sepsis guidelines recommend norepinephrine as the first-line agent.
Other vasopressors each have a slightly different profile. Epinephrine hits both blood vessel and heart receptors powerfully, making it useful in cardiac arrest and severe allergic reactions. Phenylephrine almost exclusively tightens blood vessels without speeding up the heart, which makes it a good option when a faster heart rate would be harmful. Vasopressin works through an entirely different receptor system, not the adrenergic receptors at all, and is often added as a second agent when norepinephrine alone isn’t enough. Dopamine, once commonly used, has fallen out of favor as a first choice for most types of shock because it tends to cause more heart rhythm problems.
How Vasopressors Are Given
Vasopressors are delivered as a continuous drip through an IV pump, not as a one-time injection. The dose is constantly adjusted, or “titrated,” based on real-time blood pressure readings. Nurses check the infusion site and catheter function at least every hour.
Traditionally, these drugs have been given through a central venous catheter, a large IV line threaded into a major vein near the heart. Central lines allow high concentrations of the drug to mix quickly with a large volume of blood, reducing the risk of damage to smaller veins. However, placing a central line takes time and specialized skill. Recent evidence shows that short-term, low-dose vasopressor infusion through a standard peripheral IV in the arm can be safe when protocols are followed. Guidelines now support starting vasopressors through a peripheral IV rather than delaying treatment while waiting for a central line, with the recommendation to limit peripheral infusion to 24 hours or less and to use only one vasopressor per line.
Risks and Side Effects
The same vessel-tightening effect that saves a life can cause harm if it goes too far or affects the wrong areas. Because vasopressors constrict blood vessels throughout the body, they can reduce blood flow to the fingers, toes, kidneys, and gut. Prolonged use at high doses can, in rare cases, lead to tissue damage in the extremities.
Agents that stimulate the heart can cause a rapid or irregular heartbeat. Blood pressure can also overshoot the target, placing extra strain on the heart and blood vessels. This is why continuous monitoring, often with an arterial line that reads blood pressure beat by beat, is standard during vasopressor therapy.
One specific complication is extravasation, where the drug leaks out of the vein and into the surrounding tissue. Because the drug constricts local blood vessels, the affected area becomes cold, hard, and pale. If caught quickly, an antidote can be injected into the skin around the leak site to reverse the constriction. The treatment works best within the first 12 hours, and the blanching typically reverses immediately once the antidote takes effect. This is one of the main reasons nurses monitor IV sites so frequently during vasopressor infusions.
What It’s Like for the Patient
If you or a loved one is on vasopressors, it means the medical team is managing a serious, life-threatening drop in blood pressure. The patient will be in an ICU with constant monitoring: heart rhythm on a screen, blood pressure tracked continuously, and a nurse nearby adjusting the drip. The goal is to keep MAP at or above 65 mmHg, though the target may be individualized. Different organs and different people can have different optimal pressures, so ICU teams sometimes adjust the target based on signs of adequate organ function, like urine output and mental alertness.
Vasopressors are not a long-term medication. They are a bridge, keeping blood pressure high enough to protect organs while the underlying cause of shock is treated, whether that’s antibiotics for sepsis, surgery to stop bleeding, or interventions to support a failing heart. As the underlying problem improves, the vasopressor dose is gradually reduced and eventually stopped.